MX2009007050A - Compuestos de carboxamida y su uso como inhibidores de calpaina. - Google Patents
Compuestos de carboxamida y su uso como inhibidores de calpaina.Info
- Publication number
- MX2009007050A MX2009007050A MX2009007050A MX2009007050A MX2009007050A MX 2009007050 A MX2009007050 A MX 2009007050A MX 2009007050 A MX2009007050 A MX 2009007050A MX 2009007050 A MX2009007050 A MX 2009007050A MX 2009007050 A MX2009007050 A MX 2009007050A
- Authority
- MX
- Mexico
- Prior art keywords
- carboxamide compounds
- compounds
- calpain inhibitors
- carboxamide
- tautomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a compuestos de carboxamida novedosos y a su uso para la manufactura de un medicamento. Los compuestos de carboxamida son inhibidores de calpaína (cisteína proteasas dependientes de calcio). Por lo tanto, la invención también se refiere al uso de estos compuestos de carboxamida para el tratamiento de un trastorno asociado con una elevada actividad de calpaína. Los compuestos de carboxamida son compuestos de la Fórmula General (1), en donde R1, R2, R3b, RSb, W, Y, y X tienen los significados mencionados en las reivindicaciones y en la descripción, los tautómeros de los mismos y las sales farmacéuticamente adecuadas de los mismos. En particular los compuestos tienen la Fórmula General I-Aa' y l-A.a", en donde m, E, R1, R2, R3a, R3b, R2, Ry, Rw, y Rw6* tienen los significados mencionados en las reivindicaciones; n tiene un valor de 0 1 ó 2, los tautómeros de los mismos y las sales farmacéuticamente adecuadas de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06127369 | 2006-12-29 | ||
PCT/EP2007/064617 WO2008080969A1 (en) | 2006-12-29 | 2007-12-28 | Carboxamide compounds and their use as calpain inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009007050A true MX2009007050A (es) | 2009-09-23 |
Family
ID=39226751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009007050A MX2009007050A (es) | 2006-12-29 | 2007-12-28 | Compuestos de carboxamida y su uso como inhibidores de calpaina. |
Country Status (29)
Country | Link |
---|---|
US (4) | US8436034B2 (es) |
EP (2) | EP2439205B1 (es) |
JP (1) | JP5295976B2 (es) |
KR (3) | KR101578674B1 (es) |
CN (1) | CN101616908B (es) |
AR (2) | AR064693A1 (es) |
AT (1) | ATE544758T1 (es) |
AU (1) | AU2007341232B2 (es) |
BR (1) | BRPI0721298A2 (es) |
CA (1) | CA2673580C (es) |
CL (1) | CL2007003879A1 (es) |
CO (1) | CO6190617A2 (es) |
DK (1) | DK2439205T3 (es) |
EC (1) | ECSP099476A (es) |
ES (2) | ES2381879T3 (es) |
GT (1) | GT200900186A (es) |
HK (1) | HK1138833A1 (es) |
IL (2) | IL199447A (es) |
MX (1) | MX2009007050A (es) |
MY (1) | MY147780A (es) |
NZ (2) | NZ577719A (es) |
PE (1) | PE20081609A1 (es) |
PL (1) | PL2439205T3 (es) |
PT (1) | PT2439205E (es) |
RU (2) | RU2485114C2 (es) |
TW (1) | TWI405571B (es) |
UA (1) | UA100501C2 (es) |
UY (1) | UY30850A1 (es) |
WO (1) | WO2008080969A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2485114C2 (ru) * | 2006-12-29 | 2013-06-20 | Эбботт Гмбх Унд Ко.Кг | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов |
TWI453019B (zh) * | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
PE20110672A1 (es) * | 2008-08-14 | 2011-09-25 | Bayer Cropscience Ag | 4-fenil-1-h-pirazoles insecticidas |
TWI519530B (zh) * | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
US8236798B2 (en) * | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
NZ597833A (en) * | 2009-09-28 | 2014-01-31 | Hoffmann La Roche | Benzoxazepin pi3k inhibitor compounds and methods of use |
US9051304B2 (en) * | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
WO2011137372A1 (en) | 2010-04-30 | 2011-11-03 | Abbott Cardiovascular Systems Inc. | Improved balloon catheter exhibiting rapid inflation and deflation |
CN103501784A (zh) * | 2010-12-09 | 2014-01-08 | Abbvie德国有限责任两合公司 | 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途 |
AR085013A1 (es) | 2011-01-26 | 2013-08-07 | Sanofi Aventis | Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas |
WO2013126283A1 (en) | 2012-02-20 | 2013-08-29 | E. I. Du Pont De Nemours And Company | Fungicidal pyrazoles |
CN104364247A (zh) * | 2012-04-03 | 2015-02-18 | 艾伯维德国有限责任两合公司 | 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途 |
EP3336084B1 (en) | 2013-03-29 | 2021-03-17 | Takeda Pharmaceutical Company Limited | 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors |
PL3033336T3 (pl) | 2013-08-14 | 2018-11-30 | Kalvista Pharmaceuticals Limited | Inhibitory kalikreiny w plaźmie |
TWI636047B (zh) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | 雜環衍生物 |
GB201421085D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
CA3006911A1 (en) | 2015-12-22 | 2017-06-29 | Syngenta Participations Ag | Pesticidally active pyrazole derivatives |
CN107857723A (zh) * | 2016-01-26 | 2018-03-30 | 绍兴瑞康生物科技有限公司 | 一种羧酰胺类化合物及其制备方法和应用 |
US10590084B2 (en) | 2016-03-09 | 2020-03-17 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
HUE049918T2 (hu) | 2016-05-31 | 2020-11-30 | Kalvista Pharmaceuticals Ltd | Pirazol-származékok mint plazma kallikrein inhibitorok |
GB201609603D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide |
GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
WO2018009417A1 (en) | 2016-07-05 | 2018-01-11 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
US10934261B2 (en) * | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
EP3668853B1 (en) | 2017-08-16 | 2021-09-29 | GlaxoSmithKline Intellectual Property Development Limited | Novel compounds |
IL274557B1 (en) | 2017-11-29 | 2024-05-01 | Kalvista Pharmaceuticals Ltd | Dosage forms containing a plasma kallikrein inhibitor |
GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
AU2019242387A1 (en) * | 2018-03-28 | 2020-11-19 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN114206852A (zh) | 2019-08-09 | 2022-03-18 | 卡尔维斯塔制药有限公司 | 血浆激肽释放酶抑制剂 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH21213A (en) | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
US4826835A (en) | 1985-10-23 | 1989-05-02 | Rorer Pharmaceutical Corporation | Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure |
US4743608A (en) | 1986-07-15 | 1988-05-10 | Rorer Pharmaceutical Corporation | Pyridone-pyridyl-imidazolyl and triazolyl compounds and their use as cardiotonic agents |
US4888352A (en) | 1989-03-22 | 1989-12-19 | Sterling Drug Inc. | 3,4, or 5-aryl-1H-pyrazole-1-alkanamides as antiarrhythmic agents, compositions and use |
GB9412603D0 (en) * | 1994-06-23 | 1994-08-10 | Sandoz Ltd | Organic compounds |
DE19642591A1 (de) | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
DE19650975A1 (de) | 1996-12-09 | 1998-06-10 | Basf Ag | Neue heterocyclisch substituierte Benzamide und deren Anwendung |
AU721620B2 (en) | 1996-12-11 | 2000-07-13 | Basf Aktiengesellschaft | Novel ketobenzamides and their use |
US6127556A (en) | 1996-12-31 | 2000-10-03 | G. D. Searle & Co. | Epoxide formation by continuous in-situ synthesis process |
US6083944A (en) * | 1997-10-07 | 2000-07-04 | Cephalon, Inc. | Quinoline-containing α-ketoamide cysteine and serine protease inhibitors |
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
SK14512000A3 (sk) | 1998-04-20 | 2001-04-09 | Basf Aktiengesellschaft | Substituované amidy, ich príprava a použitie |
DE19817461A1 (de) | 1998-04-20 | 1999-10-21 | Basf Ag | Neue substituierte Benzamide, deren Herstellung und Anwendung |
WO1999054305A1 (de) * | 1998-04-20 | 1999-10-28 | Basf Aktiengesellschaft | Heterocyclisch substituierte amide als calpainhemmer |
DE19818614A1 (de) | 1998-04-20 | 1999-10-21 | Basf Ag | Neue substituierte Amide, deren Herstellung und Anwendung |
BR9909819A (pt) | 1998-04-20 | 2000-12-19 | Basf Ag | Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal |
EP1080074B1 (de) * | 1998-05-25 | 2006-11-08 | Abbott GmbH & Co. KG | Heterocyclische substituierte Amide, deren Herstellung und Verwendung |
AR018915A1 (es) * | 1998-06-24 | 2001-12-12 | Smithkline Beecham Corp | Inhibidores de proteasas diacilhidrazinicos, composicion farmaceutica que la comprenden, usos de los mismos para la manufactura de un medicamento, unprocedimiento de fabricacion de dichos compuestos |
AU2001245764A1 (en) * | 2000-03-15 | 2001-09-24 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions as protease inhibitors |
JP2001261675A (ja) | 2000-03-21 | 2001-09-26 | Mitsui Chemicals Inc | ピラゾリン誘導体またはテトラヒドロピリダジン誘導体を含有する医薬 |
US6995162B2 (en) * | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
DE10114762A1 (de) | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
CA2477657C (en) * | 2002-03-05 | 2011-04-26 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | Cathepsin cysteine protease inhibitors |
EP1610263A1 (en) | 2004-06-18 | 2005-12-28 | Sicpa Holding S.A. | Item carrying at least two data storage elements |
WO2006080439A1 (ja) | 2005-01-28 | 2006-08-03 | Taisho Pharmaceutical Co., Ltd. | 三環性化合物 |
RU2485114C2 (ru) * | 2006-12-29 | 2013-06-20 | Эбботт Гмбх Унд Ко.Кг | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов |
TWI453019B (zh) * | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
-
2007
- 2007-12-28 RU RU2009129119/04A patent/RU2485114C2/ru not_active IP Right Cessation
- 2007-12-28 WO PCT/EP2007/064617 patent/WO2008080969A1/en active Application Filing
- 2007-12-28 CN CN200780051850.2A patent/CN101616908B/zh not_active Expired - Fee Related
- 2007-12-28 EP EP11195099.4A patent/EP2439205B1/en not_active Not-in-force
- 2007-12-28 EP EP07866322A patent/EP2121653B1/en active Active
- 2007-12-28 JP JP2009543479A patent/JP5295976B2/ja not_active Expired - Fee Related
- 2007-12-28 AT AT07866322T patent/ATE544758T1/de active
- 2007-12-28 UA UAA200907938A patent/UA100501C2/uk unknown
- 2007-12-28 UY UY30850A patent/UY30850A1/es not_active Application Discontinuation
- 2007-12-28 NZ NZ577719A patent/NZ577719A/en not_active IP Right Cessation
- 2007-12-28 BR BRPI0721298-4A patent/BRPI0721298A2/pt not_active IP Right Cessation
- 2007-12-28 DK DK11195099.4T patent/DK2439205T3/da active
- 2007-12-28 AR ARP070105965A patent/AR064693A1/es unknown
- 2007-12-28 KR KR1020097016007A patent/KR101578674B1/ko not_active IP Right Cessation
- 2007-12-28 NZ NZ599860A patent/NZ599860A/xx not_active IP Right Cessation
- 2007-12-28 MX MX2009007050A patent/MX2009007050A/es active IP Right Grant
- 2007-12-28 AU AU2007341232A patent/AU2007341232B2/en not_active Ceased
- 2007-12-28 TW TW096150930A patent/TWI405571B/zh not_active IP Right Cessation
- 2007-12-28 PT PT111950994T patent/PT2439205E/pt unknown
- 2007-12-28 MY MYPI20092635A patent/MY147780A/en unknown
- 2007-12-28 KR KR1020157020182A patent/KR20150090282A/ko not_active Application Discontinuation
- 2007-12-28 CL CL200703879A patent/CL2007003879A1/es unknown
- 2007-12-28 US US11/990,652 patent/US8436034B2/en active Active
- 2007-12-28 PL PL11195099T patent/PL2439205T3/pl unknown
- 2007-12-28 ES ES07866322T patent/ES2381879T3/es active Active
- 2007-12-28 KR KR1020157020180A patent/KR20150090281A/ko not_active Application Discontinuation
- 2007-12-28 ES ES11195099.4T patent/ES2536626T3/es active Active
- 2007-12-28 CA CA2673580A patent/CA2673580C/en not_active Expired - Fee Related
-
2008
- 2008-01-02 PE PE2008000057A patent/PE20081609A1/es not_active Application Discontinuation
- 2008-02-22 US US12/072,065 patent/US7799809B2/en not_active Expired - Fee Related
- 2008-02-22 US US12/070,941 patent/US7728012B2/en not_active Expired - Fee Related
-
2009
- 2009-06-18 IL IL199447A patent/IL199447A/en not_active IP Right Cessation
- 2009-06-26 CO CO09066778A patent/CO6190617A2/es active IP Right Grant
- 2009-06-29 GT GT200900186A patent/GT200900186A/es unknown
- 2009-06-29 EC EC2009009476A patent/ECSP099476A/es unknown
-
2010
- 2010-05-14 HK HK10104679.8A patent/HK1138833A1/xx not_active IP Right Cessation
- 2010-07-15 AR ARP100102569A patent/AR077477A2/es unknown
-
2013
- 2013-02-01 RU RU2013104459/04A patent/RU2013104459A/ru not_active Application Discontinuation
- 2013-03-25 US US13/849,826 patent/US9139557B2/en not_active Expired - Fee Related
-
2014
- 2014-03-11 IL IL231463A patent/IL231463A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007050A (es) | Compuestos de carboxamida y su uso como inhibidores de calpaina. | |
NZ596000A (en) | Carboxamide compounds and their use as calpain inhibitors | |
TW200626601A (en) | Novel compounds | |
SI1585739T1 (sl) | Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
WO2007139856A3 (en) | Heterobicyclic metalloprotease inhibitors | |
HK1119699A1 (en) | Pyridopyrimidinone inhibitors of pi3kalpha | |
MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2006028958A3 (en) | Pyridyl inhibitors of hedgehog signalling | |
WO2006128184A3 (en) | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
MX2009004441A (es) | Derivados de indazol utiles como inhibidores de las isoformas de higado. | |
MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
MX2009005217A (es) | Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos. | |
WO2007047646A3 (en) | Substituted dihydro-isoindolones useful in treating kinase disorders | |
MX336637B (es) | Compuestos carboxamida y su uso como inhibidores de calpaina. | |
MXPA05010521A (es) | Inhibidores de cinasa de amida de bifenilcarboxilica p38. | |
UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
TW200628153A (en) | Novel compounds | |
TW200612940A (en) | Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament | |
MX2013006419A (es) | Compuestos carboxamida y su uso como inhibidores de calpaina v. | |
IL189286A0 (en) | Novel cysteine protease inhibitors and their therapeutic applications | |
GB0412314D0 (en) | Compounds | |
GB0308201D0 (en) | Novel compounds | |
IL161842A0 (en) | 2-Amino-4-heteroarylethyl-thiazoline derivatives and their use as inhibitors of inducible no-synthase | |
MX2008007195A (es) | Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |